| P50 | author | Patricia Swanson | Q92495173 |
| | Rafael A Delgado-Ruiz | Q45718280 |
| P2093 | author name string | Georgios Romanos | |
| P2860 | cites work | Vitamin D and Calcium Supplementation to Prevent Fractures in Adults: U.S. Preventive Services Task Force Recommendation Statement | Q22305319 |
| | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Q27860647 |
| | Treatment Considerations for a Full-Mouth Reconstruction of a Transgender Patient | Q47653708 |
| | Surgical and pharmacological reassignment: influence on transsexual cardiovascular risk profile | Q47707632 |
| | Ethical Concerns About Emerging Treatment Paradigms for Gender Dysphoria | Q47768994 |
| | Dental fear among transgender individuals - a cross-sectional survey | Q48169616 |
| | Bone mass, bone geometry, and body composition in female-to-male transsexual persons after long-term cross-sex hormonal therapy | Q49024600 |
| | Prevalence of low bone mass in relation to estrogen treatment and body composition in male-to-female transsexual persons | Q49146309 |
| | Long-term evaluation of cross-sex hormone treatment in transsexual persons | Q49156457 |
| | Should Dental Care Make a Transition? | Q49494644 |
| | Treating a transgender patient: overview of the guidelines. | Q50613629 |
| | Transsexualism and osteoporosis. | Q50860275 |
| | Management of transgenderism | Q51275591 |
| | International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis. | Q51565745 |
| | Development of a novel method for surgical implant design optimization through noninvasive assessment of local bone properties | Q51643464 |
| | Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals. | Q51749719 |
| | Eighteen-Year Effect of Androgen Therapy on Bone Mineral Density in Trans(gender) Men. | Q52699560 |
| | Assessment of implant cumulative survival rates in sites with different bone density and related prognostic factors: an 8-year retrospective study of 2,684 implants. | Q53275453 |
| | Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline | Q56803758 |
| | Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease | Q72234300 |
| | The diagnosis of osteoporosis | Q72846752 |
| | Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study | Q74141058 |
| | Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women | Q74293112 |
| | Androgens and bone | Q79811504 |
| | Effects of Dietary Calcium Supplementation on Bone Metabolism, Kidney Mineral Concentrations, and Kidney Function in Rats Fed a High-Phosphorus Diet | Q85328432 |
| | Low Skeletal Bone Mineral Density Does Not Affect Dental Implants | Q88112598 |
| | Osseointegration in osteoporotic-like condition: A systematic review of preclinical studies | Q88913917 |
| | Prognosis of dental implants in patients with low bone density: A systematic review and meta-analysis | Q90096969 |
| | Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and Transmen | Q90405151 |
| | Osteoporosis and Bone Health in Transgender Persons | Q91552154 |
| | Bone turnover: Biology and assessment tools | Q93199443 |
| | General Diseases Influence on Peri-Implantitis Development: a Systematic Review | Q28080199 |
| | Addressing Health Disparities via Coordination of Care and Interprofessional Education: Lesbian, Gay, Bisexual, and Transgender Health and Oral Health Care | Q30245083 |
| | Does bone mineral density influence the primary stability of dental implants? A systematic review | Q33920137 |
| | Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults | Q34438584 |
| | Endocrine intervention for transsexuals | Q35544192 |
| | Biomechanical, Biologic, and Clinical Outcomes of Undersized Implant Surgical Preparation: A Systematic Review. | Q36197734 |
| | Bone quality, quantity and metabolism in terms of dental implantation | Q37288837 |
| | Role of primary stability for successful osseointegration of dental implants: Factors of influence and evaluation. | Q37415709 |
| | Estrogens as regulators of bone health in men. | Q37520591 |
| | Hormone therapy for transgender patients | Q37531083 |
| | Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis | Q37661855 |
| | Hypercalcaemia and hypocalcaemia: finding the balance | Q37736066 |
| | Use of bone turnover markers in clinical practice | Q38057946 |
| | Epidemiology of fracture risk with advancing age. | Q38119929 |
| | Progress on the road to better medical care for transgender patients | Q38182314 |
| | Safety of hormonal treatment in transgenders | Q38182316 |
| | Estrogen and bone health in men and women | Q38306105 |
| | Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. | Q38385765 |
| | Gender incongruence/gender dysphoria and its classification history | Q38702115 |
| | Dental implants in patients with osteoporosis: a systematic review with meta-analysis | Q38708351 |
| | Transient modulation of calcium and parathyroid hormone stimulates bone formation | Q38740087 |
| | Tapered Implants in Dentistry: Revitalizing Concepts with Technology: A Review | Q38755288 |
| | Transgender people: health at the margins of society. | Q38870866 |
| | LGBT Coverage in U.S. Dental Schools and Dental Hygiene Programs: Results of a National Survey | Q39116391 |
| | Osteocalcin and its endocrine functions | Q39131872 |
| | Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability | Q39385131 |
| | Ten Most Important Things to Know About Caring for Transgender Patients | Q39439847 |
| | Prevalence of Gender Nonconformity in Flanders, Belgium | Q41583052 |
| | Peri-implant bone microstructure determines dynamic implant cut-out | Q43968793 |
| | Body composition, volumetric and areal bone parameters in male-to-female transsexual persons | Q44375321 |
| | Bone mass, bone turnover, vitamin D, and estrogen receptor gene polymorphisms in male to female transsexuals: effects of estrogenic treatment on bone metabolism of the male | Q44600056 |
| | Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study | Q45122719 |
| | Comparative evaluation of serum levels of main minerals and postmenopausal osteoporosis | Q45396992 |
| | Gender identities and gender dysphoria in the Netherlands | Q45754871 |
| | Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study. | Q47204868 |
| | Strategies for student services for lesbian, gay, bisexual, and transgender students in dental schools | Q47332608 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P577 | publication date | 2019-06-01 | |
| P1433 | published in | Journal of Clinical Medicine | Q27724774 |
| P1476 | title | Systematic Review of the Long-Term Effects of Transgender Hormone Therapy on Bone Markers and Bone Mineral Density and Their Potential Effects in Implant Therapy | |
| P478 | volume | 8 | |